Expression of epidermal growth factor receptor and vascular endothelial growth factor in vaginal squamous cell cancer

被引：4

作者：

Brunner, Andreas ^{[1
]}

Grimm, Christoph ^{[1
]}

Polterauer, Stephan ^{[1
]}

Hefler, Lukas ^{[1
]}

Stani, Josefine ^{[2
]}

Dudek, Grazyna ^{[3
]}

Horvat, Reinhard ^{[2
]}

机构：

[1] Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria

[2] Med Univ Vienna, Dept Pathol, A-1090 Vienna, Austria

[3] Med Univ Vienna, Mol Oncol Grp, A-1090 Vienna, Austria

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2011年 / 204卷 / 02期

关键词：

epidermal growth factor receptor; prognosis; squamous cell cancer; vaginal cancer; vascular endothelial growth factor; LUNG-CANCER; CERVICAL-CANCER; TUMOR ANGIOGENESIS; PROGNOSTIC VALUE; NODE METASTASES; POOR-PROGNOSIS; UTERINE CERVIX; VEGF-C; CARCINOMA; SURVIVAL;

D O I：

10.1016/j.ajog.2010.09.031

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

OBJECTIVE: Primary invasive squamous cell carcinoma of the vagina is a rare neoplasm. Investigations concerning the potential of new therapeutic targets are limited. STUDY DESIGN: A total of 34 patients with primary invasive squamous cell carcinoma of the vagina was identified, who were treated at our institution between 1994 and 2008. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) expression was assessed using immunohistochemistry from paraffin-embedded tissue blocks. RESULTS: EGFR was expressed in 33 of 34 (97.1%) and VEGF was expressed in 12 of 34 cases (35.3%). There was no statistically significant relationship between clinicopathologic parameters (clinical stage, grading, tumor size), patient survival, and EGFR and VEGF expression. CONCLUSION: VEGF was moderate and EGFR was frequently expressed in invasive squamous cell carcinoma of the vagina. In our sample size, immunohistochemical staining was not statistically significantly associated with prognosis.

引用

页码：171.e1 / 171.e6

页数：6

共 39 条

[1] Prognostic value of vascularity and vascular endothelial growth factor expression in non-small cell lung cancer [J].

Baillie, R ;

Carlile, J ;

Pendleton, N ;

Schor, AM .

JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (02) :116-120

[2]

Barnes CJ, 2003, MOL CANCER THER, V2, P345

[3] Carcinoma of the vagina [J].

Beller, U ;

Maisonneuve, P ;

Benedet, JL ;

Heintz, APM ;

Ngan, HYS ;

Pecorelli, S ;

Odicino, F ;

Creasman, WT .

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2003, 83 :27-39

[4] Overexpression of epidermal growth factor type-l receptor (EGF-R1) in cervical cancer: Implications for Cetuximab-mediated therapy in recurrent/metastatic disease [J].

Bellone, Stefania ;

Frera, Glanluca ;

Landolfi, Gianpiero ;

Romani, Chiara ;

Bandiera, Efisabetta ;

Tognon, Gen-Nana ;

Roman, Juan J. ;

Burnett, Alexander F. ;

Pecorelli, Sergio ;

Santin, Alessandro D. .

GYNECOLOGIC ONCOLOGY, 2007, 106 (03) :513-520

[5]

Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209

[6]

BERCHUCK A, 1990, OBSTET GYNECOL, V76, P381

[7]

BEREK JS, 2000, PRACTICAL ONCOLOGY

[8] Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts [J].

Bozec, A. ;

Formento, P. ;

Lassalle, S. ;

Lippens, C. ;

Hofman, P. ;

Milano, G. .

BRITISH JOURNAL OF CANCER, 2007, 97 (01) :65-72

[9]

Brabender J, 2001, CLIN CANCER RES, V7, P1850

[10] EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION AND THE PRESENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS [J].

CHAPMAN, WB ;

LORINCZ, AT ;

WILLETT, GD ;

WRIGHT, VC ;

KURMAN, RJ .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1992, 11 (03) :221-226

← 1 2 3 4 →